paediatrics
paediatrics

Genetic Diversity and Epidemiology of Enteroviruses and Rhinoviruses in Children Hospitalized with Acute Respiratory Infections in Novosibirsk, Russia (2023-2024)

Viruses. 2024 Dec 16;16(12):1924. doi: 10.3390/v16121924. ABSTRACT Rhinoviruses and respiratory enteroviruses remain among the leading causes of acute respiratory infections, particularly in children. Little is …

Beyond Poliomyelitis: A 21-Year Study of Non-Polio Enterovirus Genotyping and Its Relevance in Acute Flaccid Paralysis in São Paulo, Brazil

Viruses. 2024 Dec 1;16(12):1875. doi: 10.3390/v16121875. ABSTRACT In the context of the near-global eradication of wild poliovirus, the significance of non-polio enteroviruses (NPEVs) in causing …

The Epidemiology, Clinical, and Economic Burdens of Respiratory Syncytial Virus Infections Amongst Hospitalized Children Under 5 Years of Age in Jordan: A National Multi-Center Cross-Sectional Study

Viruses. 2024 Nov 30;16(12):1867. doi: 10.3390/v16121867. ABSTRACT Respiratory syncytial virus (RSV) has been recognized as a highly important cause of morbidity and mortality among children …

Evaluating the Impact of N-Glycan Sequon Removal in the p27 Peptide on RSV F Protein Immunogenicity and Functionality

Viruses. 2024 Nov 28;16(12):1848. doi: 10.3390/v16121848. ABSTRACT Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infections in young children, elderly …

Tissue-Specific DNA Methylation Changes in CD8+ T Cells During Chronic Simian Immunodeficiency Virus Infection of Infant Rhesus Macaques

Viruses. 2024 Nov 27;16(12):1839. doi: 10.3390/v16121839. ABSTRACT Robust CD8+ T cell responses are critical for the control of HIV infection in both adults and children. …

BNT162b2 mRNA vaccine elicits robust virus-specific antibodies but poor cross-protective CD8+ memory T cell responses in adolescents with type 1 diabetes

J Microbiol Immunol Infect. 2025 Jan 3:S1684-1182(25)00001-5. doi: 10.1016/j.jmii.2024.12.009. Online ahead of print. ABSTRACT BACKGROUND: COVID-19 mRNA vaccines have demonstrated 95 % efficacy in the …